文献速递妇科

晚期上皮性卵巢癌患者的生活质量与生存显著相关:NRG肿瘤学/妇科肿瘤学组(GOG-0218)研究的辅助数据分析

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study.
PubMed 文献 · Gynecol Oncol · 2017-07-23

该辅助数据分析纳入GOG-0218研究中1152例晚期上皮性卵巢癌患者,按基线FACT-O TOI评分四分位分组,Q1组283例,Q2-4组869例。Q1组与Q2-4组相比中位OS更差(37.5 vs 45.6个月,P=0.001),中位PFS为12.5 vs 13.1个月(P=0.096)。基线FACT-O TOI评分每增加5分,疾病进展风险HR 0.974(95%CI 0.953-0.995,P=0.018),死亡风险HR 0.963(95%CI 0.939-0.987,P=0.003)。FACT-O TOI评分改善较恶化的患者中位PFS和OS均更长。

要点

  • 基线FACT-O TOI评分Q1组与Q2-4组相比中位OS更差(37.5 vs 45.6个月,P=0.001)。
  • 基线FACT-O TOI每增加5分,疾病进展风险HR 0.974(95%CI 0.953-0.995,P=0.018)。
  • FACT-O TOI评分改善较恶化与更长中位PFS和OS相关(各亚组P<0.001或P=0.001)。

核心结论

  • 基线FACT-O TOI评分是晚期上皮性卵巢癌患者PFS和OS的独立预后因素。
  • FACT-O TOI评分改善较恶化与显著更好的PFS和OS相关。

研究设计与样本

  • GOG-0218研究的辅助数据分析,纳入基线及至少一次随访FACT-O TOI评估完整的晚期上皮性卵巢癌患者1152例。
  • 基线FACT-O TOI评分按四分位分组,Q1组283例,Q2-4组869例。
  • 采用log-rank检验和多变量Cox回归(校正年龄、分期、术后残留病灶大小和体能状态)比较Q1与Q2-4组结局。

主要发现

  • 基线FACT-O TOI平均评分Q1组为47.5,Q2-4组为74.7(P<0.001)。
  • Q1组与Q2-4组相比中位OS更差(37.5 vs 45.6个月,P=0.001),中位PFS为12.5 vs 13.1个月(P=0.096)。
  • 基线FACT-O TOI每增加5分,Q2-4组疾病进展风险HR 0.974(95%CI 0.953-0.995,P=0.018),死亡风险HR 0.963(95%CI 0.939-0.987,P=0.003)。
  • FACT-O TOI评分改善较恶化与更长中位PFS相关(Q1组:12.7 vs 8.6个月,P=0.001;Q2-4组:16.7 vs 11.1个月,P<0.001)。
  • FACT-O TOI评分改善较恶化与更长中位OS相关(Q1组:40.8 vs 16个月,P<0.001;Q2-4组:54.4 vs 33.6个月,P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Evaluate association between baseline quality of life (QOL) and changes in QOL measured by FACT-O TOI with progression-free disease (PFS) and overall survival (OS) in advanced epithelial ovarian cancer (EOC). METHODS: Patients enrolled in GOG-0218 with completed FACT-O TOI assessments at baseline and at least one follow-up assessment were eligible. Baseline FACT-O TOI scores were sorted by quartiles (Q1-4) and outcomes compared between Q1 and Q2-4 with log-rank statistic and multivariate Cox regression adjusting for age, stage, post-surgical residual disease size, and performance status (PS). Trends in FACT-O TOI scores from baseline to the latest follow-up assessment were evaluated for impact on intragroup (Q1 or Q2-4) outcome by log-rank analysis. RESULTS: Of 1152 eligible patients, 283 formed Q1 and 869 formed Q2-4. Mean baseline FACT-O TOI scores were 47.5 for Q1 vs. 74.7 for Q2-4 (P<0.001). Q1 compared to Q2-4 had worse median OS (37.5 vs. 45.6months, P=0.001) and worse median PFS (12.5 vs. 13.1months, P=0.096). Q2-4 patients had decreased risks of disease progression (HR 0.974, 95% CI 0.953-0.995, P=0.018), and death (HR 0.963, 95% CI 0.939-0.987, P=0.003) for each five-point increase in baseline FACT-O TOI. Improving versus worsening trends in FACT-O TOI scores were associated with longer median PFS (Q1: 12.7 vs. 8.6months, P=0.001; Q2-4: 16.7 vs. 11.1months, P<0.001) and median OS (Q1: 40.8 vs. 16months, P<0.001; Q2-4: 54.4 vs. 33.6months, P<0.001). CONCLUSIONS: Baseline FACT-O TOI scores were independently prognostic of PFS and OS while improving compared to worsening QOL was associated with significantly better PFS and OS in women with EOC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Phippen NT, Secord AA, Wolf S, et al. Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study. Gynecol Oncol. 2017. PMID: 28743369. doi:10.1016/j.ygyno.2017.07.121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。